Amissa, founded with the mission to advance dementia science, focuses on improving Alzheimer's caregiving through innovative technology. The company offers remote patient monitoring software that utilizes predictive analytics to recommend modified behaviors, potentially delaying the onset of Alzheimer's disease. By collecting real-world health and behavior data via smartwatches, Amissa aims to discover digital biomarkers of early Alzheimer's, addressing the slow and costly nature of traditional clinical research.
Notable affiliated individuals and investors include experts in healthcare technology and Alzheimer's research, although specific names are not publicly disclosed. Key achievements include the development of a free Apple and Android smartwatch app that passively collects extensive health data, generating 200,000 times more real-world data than traditional clinician visits. Amissa's impact lies in its potential to revolutionize Alzheimer's care by providing actionable insights and facilitating early intervention through advanced data analytics.
